ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
January 24, 2024 08:30 ET
|
Elevai Labs Inc.
ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
January 17, 2024 08:30 ET
|
Elevai Labs Inc.
ELEVAI Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
January 16, 2024 08:30 ET
|
Elevai Labs Inc.
ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million
January 05, 2024 08:30 ET
|
NurExone Biologic Inc
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million
ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
January 02, 2024 09:15 ET
|
Elevai Labs Inc.
ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023
December 11, 2023 09:15 ET
|
Elevai Labs Inc.
Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023
NurExone Biologic Extends Spinal Cord Injury Therapy Portfolio With New RNA Sequences Promoting Healing and Regeneration
November 29, 2023 08:30 ET
|
NurExone Biologic Inc
NurExone Biologic expands its portfolio of products to address spinal cord injuries & neuron regeneration in CNS indications
NurExone Biologic to Present Exosome-Based Therapy for Spinal Cord Injury in Regenerative Medicine Session at Upcoming Extracellular Vesicles Forum
October 05, 2023 08:30 ET
|
NurExone Biologic Inc
NurExone Biologic will present at the EVs Forum in Cambridge presents advances in exosome therapy for spinal cord injuries, highlighting ExoPTEN potential
Exosomes Market Size to Surpass USD 2,707.8 million by 2032 at Sustained CAGR of 34.2% - Market.us Study
May 08, 2023 09:29 ET
|
Market.Us
New York, May 08, 2023 (GLOBE NEWSWIRE) -- The exosomes market size is projected to surpass around USD 2,707.8 Million by 2032 and it is poised to reach a CAGR of 34.2% from 2023 to 2032. The global...
Exosome Technologies Market Value to Reach USD 343.5 Mn by 2031, rising at a CAGR of 24.8%: TMR Study
May 05, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 05, 2023 (GLOBE NEWSWIRE) -- The global exosome technologies market was valued at USD 47.3 Mn in 2022 and is projected to exceed USD 343.5 Mn by 2031. ...